암 진단 분야 AI 시장 규모는 향후 몇 년 동안 빠르게 성장하여 2029년에는 16억 4,000만 달러에 달할 것으로 예상되며, 연평균 19.9%의 성장률을 기록할 것으로 예상됩니다. 예측 기간의 성장은 설명 가능한 AI의 출현, 전 세계 의료 지출의 증가, 전자 의료 기록(EHR)과의 통합, 개인화된 의료의 채택, AI 알고리즘의 지속적인 발전에 기인합니다. 예측 기간의 주요 동향으로는 이미징 기술의 발전, 기술 융합, 헬스케어와 하이테크 기업의 협업, 디지털 병리학의 부상, 병리조직학의 자동화 등이 있습니다.
암 유병률의 증가는 암 진단 시장에서 인공지능의 성장을 촉진할 것으로 예상됩니다. 암은 신체의 다른 부위로 침범하거나 전이될 수 있는 비정상적인 세포 증식을 특징으로 하는 질병군을 말합니다. 암 치료에 AI를 통합하는 것은 효율성, 정확성, 개인화된 치료 옵션을 개선하고 궁극적으로 암 환자의 치료 결과를 개선하는 것을 목표로 합니다. 예를 들어, 2024년 5월 미국 정부 기관인 국립암연구소는 2024년 미국에서 약 200만 명의 암 환자가 새로 진단받고 61만1000명 이상이 사망할 것으로 예상했으며, 2040년까지 전 세계 신규 암 환자는 2990만 명, 암으로 인한 사망자는 1530만 명에 달할 것으로 예측했습니다. 결과적으로 암 유병률의 증가는 암 진단 시장에서 인공지능의 채택을 촉진하고 있습니다.
암 진단 분야 AI 시장의 주요 기업들은 암 진단을 위한 AI 기반 디지털 병리 솔루션의 발전으로 괄목할 만한 성장세를 보이고 있습니다. 이러한 솔루션은 AI 알고리즘을 활용하여 다양한 조직 유형에서 암 및 기타 진단적 특징을 감지하고, 정확하고 시기적절한 암 진단을 제공하며, 사례의 우선순위를 정하고, 재현성 있는 진단을 보장합니다. 예를 들어, 2023년 11월, Dedalus와 Ibex Medical Analytics는 유럽 전역의 암 진단을 위한 통합 End-to-End AI 기반 디지털 병리 솔루션을 발표했습니다. 이 솔루션은 정확도 향상, AI를 활용한 의사결정 지원 도구 제공, 보고 간소화, 검사실 효율성 개선, 진단 신뢰도 향상을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 암 진단 분야 AI PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 암 진단 분야 AI 시장 : 성장률 분석
- 세계의 암 진단 분야 AI 시장 실적 : 규모와 성장, 2019-2024
- 세계의 암 진단 분야 AI 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 암 진단 분야 AI 전체 시장(TAM)
제6장 시장 세분화
- 세계의 암 진단 분야 AI 시장 : 구성요소별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 소프트웨어 솔루션
- 하드웨어
- 서비스
- 세계의 암 진단 분야 AI 시장 암 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 유방암
- 폐암
- 뇌종양
- 피부암과 자궁경부암
- 전립선암과 대장암
- 기타 암 종류
- 세계의 암 진단 분야 AI 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 스크리닝과 진단
- 종양 특정
- 감시
- 세계의 암 진단 분야 AI 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 진단 센터
- 의료 조사기관
- 임상시험수탁기관
- 세계의 암 진단 분야 AI 시장 소프트웨어 솔루션 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 머신러닝 소프트웨어
- 딥러닝 소프트웨어
- 이미지 분석 소프트웨어
- 세계의 암 진단 분야 AI 시장, 하드웨어 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- AI 탑재 영상 시스템
- 진단 장비
- 세계의 암 진단 분야 AI 시장, 서비스 종류별 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- AI 통합 서비스
- 컨설팅 및 트레이닝 서비스
- 서포트 및 유지보수 서비스
제7장 지역별·국가별 분석
- 세계의 암 진단 분야 AI 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 암 진단 분야 AI 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 암 진단 분야 AI 시장 : 경쟁 구도
- 암 진단 분야 AI 시장 : 기업 개요
- Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
- Tempus Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Guardant Health
- Lunit Inc.
- Paige AI Inc.
- Ada Health GmbH
- Viz.ai Inc.
- Butterfly Network Inc.
- Insilico Medicine
- BenevolentAI SA SA
- Enlitic Inc.
- Ibex Medical Analytics
- Kheiron Medical Technologies Limited
- CureMetrix Inc.
- CancerIQ Inc.
- MultiplAI Health
- Freenome Holdings Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 암 진단 분야 AI 시장 2029 : 새로운 기회를 제공하는 국가
- 암 진단 분야 AI 시장 2029 : 새로운 기회를 제공하는 부문
- 암 진단 분야 AI 시장 2029 : 성장 전략
제36장 부록
ksm
AI in cancer diagnostics involves employing artificial intelligence technologies such as machine learning and deep learning to analyze medical images, genetic data, or patient histories for aiding in the early detection, diagnosis, and prognosis of cancer. These systems can detect patterns and anomalies in data that may elude human perception, thereby enhancing diagnostic accuracy and efficiency.
The primary components of AI in cancer diagnostics include software solutions, hardware, and services. Software solutions utilize artificial intelligence (AI) and machine learning (ML) technologies to enhance the accuracy and efficiency of cancer detection, prognosis, and treatment selection. Various types of cancer, including breast cancer, lung cancer, brain tumors, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and others, are addressed. These applications encompass screening and diagnosis, tumor identification, and monitoring, and are utilized by a range of end-users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.
The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The AI in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging.
The AI in cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.64 billion in 2029 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare it spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.
The rising prevalence of cancer is expected to drive the growth of artificial intelligence in the cancer diagnostics market. Cancer refers to a group of diseases characterized by abnormal cell growth that can invade or spread to other parts of the body. The integration of AI in cancer care aims to improve efficiency, accuracy, and personalized treatment options, ultimately enhancing outcomes for cancer patients. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that approximately 2 million new cancer cases would be diagnosed in the U.S. in 2024, with over 611,000 deaths expected. By 2040, global new cancer cases are anticipated to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the growing prevalence of cancer is driving the adoption of artificial intelligence in the cancer diagnostics market.
Leading companies in the AI in cancer diagnostics market are experiencing notable growth driven by advancements in AI-powered digital pathology solutions for cancer diagnosis. These solutions utilize AI algorithms to detect cancer and other diagnostic features in various tissue types, offering accurate and timely cancer diagnosis, supporting case prioritization, and ensuring reproducible diagnoses. For instance, in November 2023, Dedalus & Ibex Medical Analytics introduced an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to enhance accuracy, provide AI-powered decision support tools, streamline reporting, improve laboratory efficiency, and boost diagnostic confidence.
In December 2023, Lunit, a South Korean AI company, acquired Volpara for $193 million, aiming to establish the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market. Volpara's extensive presence in over 2,000 medical sites across the U.S. and its vast database of over 100 million high-quality mammogram images position it as a valuable addition to Lunit's capabilities. Volpara, based in New Zealand, specializes in providing AI-powered software for personalized screening and early detection of breast cancer.
Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ai in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Component: Software Solutions; Hardware; Services
- 2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
- 3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
- 4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations
- Subsegments:
- 1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
- 2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
- 3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services
- Companies Mentioned: Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. AI In Cancer Diagnostics Market Characteristics
3. AI In Cancer Diagnostics Market Trends And Strategies
4. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global AI In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global AI In Cancer Diagnostics Market Growth Rate Analysis
- 5.4. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global AI In Cancer Diagnostics Total Addressable Market (TAM)
6. AI In Cancer Diagnostics Market Segmentation
- 6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software Solutions
- Hardware
- Services
- 6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer And Cervical Cancer
- Prostate And Colorectal Cancer
- Other Cancer Types
- 6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Screening And Diagnosis
- Tumor Identification
- Monitoring
- 6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Medical Research Institutes
- Contract Research Organizations
- 6.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Machine Learning Software
- Deep Learning Software
- Image Analysis Software
- 6.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- AI-Powered Imaging Systems
- Diagnostic Devices
- 6.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- AI Integration Services
- Consulting And Training Services
- Support And Maintenance Services
7. AI In Cancer Diagnostics Market Regional And Country Analysis
- 7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific AI In Cancer Diagnostics Market
- 8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China AI In Cancer Diagnostics Market
- 9.1. China AI In Cancer Diagnostics Market Overview
- 9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India AI In Cancer Diagnostics Market
- 10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan AI In Cancer Diagnostics Market
- 11.1. Japan AI In Cancer Diagnostics Market Overview
- 11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia AI In Cancer Diagnostics Market
- 12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia AI In Cancer Diagnostics Market
- 13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea AI In Cancer Diagnostics Market
- 14.1. South Korea AI In Cancer Diagnostics Market Overview
- 14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe AI In Cancer Diagnostics Market
- 15.1. Western Europe AI In Cancer Diagnostics Market Overview
- 15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK AI In Cancer Diagnostics Market
- 16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany AI In Cancer Diagnostics Market
- 17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France AI In Cancer Diagnostics Market
- 18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy AI In Cancer Diagnostics Market
- 19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain AI In Cancer Diagnostics Market
- 20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe AI In Cancer Diagnostics Market
- 21.1. Eastern Europe AI In Cancer Diagnostics Market Overview
- 21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia AI In Cancer Diagnostics Market
- 22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America AI In Cancer Diagnostics Market
- 23.1. North America AI In Cancer Diagnostics Market Overview
- 23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA AI In Cancer Diagnostics Market
- 24.1. USA AI In Cancer Diagnostics Market Overview
- 24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada AI In Cancer Diagnostics Market
- 25.1. Canada AI In Cancer Diagnostics Market Overview
- 25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America AI In Cancer Diagnostics Market
- 26.1. South America AI In Cancer Diagnostics Market Overview
- 26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil AI In Cancer Diagnostics Market
- 27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East AI In Cancer Diagnostics Market
- 28.1. Middle East AI In Cancer Diagnostics Market Overview
- 28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa AI In Cancer Diagnostics Market
- 29.1. Africa AI In Cancer Diagnostics Market Overview
- 29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. AI In Cancer Diagnostics Market Competitive Landscape
- 30.2. AI In Cancer Diagnostics Market Company Profiles
- 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis
31. AI In Cancer Diagnostics Market Other Major And Innovative Companies
- 31.1. Guardant Health
- 31.2. Lunit Inc.
- 31.3. Paige AI Inc.
- 31.4. Ada Health GmbH
- 31.5. Viz.ai Inc.
- 31.6. Butterfly Network Inc.
- 31.7. Insilico Medicine
- 31.8. BenevolentAI SA SA
- 31.9. Enlitic Inc.
- 31.10. Ibex Medical Analytics
- 31.11. Kheiron Medical Technologies Limited
- 31.12. CureMetrix Inc.
- 31.13. CancerIQ Inc.
- 31.14. MultiplAI Health
- 31.15. Freenome Holdings Inc.
32. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market
34. Recent Developments In The AI In Cancer Diagnostics Market
35. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 AI In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 AI In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 AI In Cancer Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
